TC-I 2014

• Description:

  TC-I 2014 shows antiallodynic properties in pain models. TC-I 2014 is a potent and orally active Benzimidazole-containing transient receptor potential melastatin 8 antagonist (IC50: 0.8 nM, 3.0 nM, and 4.4 nM for canine, human and rat channels respectively) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  467.41

• Molecular Formula:

  C23H19F6N3O

• Notes:

  Research use only, not for human use.

• Receptor:

  TRP/TRPV Channel

• CAS Number:

  1221349-53-6